Osimertinib is a 3rd generation EGFR-TKI targeting NSCLC with EGFR mutations, treats EGFR Ex19Del and EGFR L858R mutations, with CNS metastasis activity.,
Sale!
Lucius
Replica: EGFRm NSCLC Targeted by Osimertinib
Original price was: $747.00.$588.00Current price is: $588.00.
Osimertinib is a 3rd generation EGFR-TKI targeting NSCLC with EGFR mutations, treats EGFR Ex19Del and EGFR L858R mutations, with CNS metastasis activity.,
Reviews
There are no reviews yet.